Mirae Asset Global Investments
NVO

Mirae Asset Global Investments’s Novo Nordisk NVO Stock Holding History

Mirae Asset Global Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3M Buy
297,881
+286,034
+2,414% +$12.3M 0.02% 378
2026
Q1 		$435K Sell
11,847
-491,231
-98% -$23.3M ﹤0.01% 959
2025
Q4 		$25.6M Buy
503,078
+40,283
+9% +$2.06M 0.07% 232
2025
Q3 		$25.7M Sell
462,795
-543,611
-54% -$31.8M 0.08% 202
2025
Q2 		$69.5M Sell
1,006,406
-588,138
-37% -$40M 0.24% 81
2025
Q1 		$85.4M Buy
1,594,544
+864,579
+118% +$71.4M 0.35% 56
2024
Q4 		$63.2M Buy
729,965
+254,475
+54% +$27.5M 0.26% 74
2024
Q3 		$57.4M Buy
475,490
+198,891
+72% +$26.5M 0.25% 74
2024
Q2 		$40M Buy
276,599
+32,298
+13% +$4.28M 0.2% 87
2024
Q1 		$31.4M Buy
244,301
+56,060
+30% +$6.67M 0.07% 276
2023
Q4 		$19.5M Sell
188,241
-2,364
-1% -$234K 0.04% 433
2023
Q3 		$17.3M Buy
190,605
+16,485
+9% +$1.45M 0.04% 445
2023
Q2 		$14.1M Buy
174,120
+44,990
+35% +$3.68M 0.03% 519
2023
Q1 		$10.3M Sell
129,130
-245,664
-66% -$17.4M 0.02% 637
2022
Q4 		$25.3M Buy
374,794
+192,582
+106% +$11.3M 0.07% 319
2022
Q3 		$9.1M Sell
182,212
-46,154
-20% -$2.47M 0.02% 612
2022
Q2 		$10.1M Buy
228,366
+101,168
+80% +$5.61M 0.03% 600
2022
Q1 		$7.06M Sell
127,198
-1,662
-1% -$85.3K 0.01% 770
2021
Q4 		$7.22M Sell
128,860
-5,030
-4% -$272K 0.02% 783
2021
Q3 		$6.43M Buy
133,890
+5,574
+4% +$269K 0.02% 770
2021
Q2 		$5.37M Sell
128,316
-2,268
-2% -$87.9K 0.02% 800
2021
Q1 		$4.4M Sell
130,584
-1,055,702
-89% -$37.6M 0.02% 756
2020
Q4 		$41.4M Buy
1,186,286
+527,296
+80% +$18.2M 0.15% 164
2020
Q3 		$22.8M Buy
658,990
+44,492
+7% +$1.48M 0.11% 209
2020
Q2 		$20.1M Buy
614,498
+391,898
+176% +$12.5M 0.12% 203
2020
Q1 		$6.7M Sell
222,600
-39,540
-15% -$1.18M 0.05% 367
2019
Q4 		$7.59M Buy
262,140
+129,586
+98% +$3.59M 0.05% 417
2019
Q3 		$3.43M Hold
132,554
– – 0.02% 565
2019
Q2 		$3.38M Hold
132,554
– – 0.02% 565
2019
Q1 		$3.47M Buy
132,554
+21,312
+19% +$524K 0.03% 499
2018
Q4 		$2.56M Sell
111,242
-79,232
-42% -$1.76M 0.02% 541
2018
Q3 		$4.49M Buy
190,474
+50,976
+37% +$1.24M 0.03% 442
2018
Q2 		$3.22M Sell
139,498
-86,156
-38% -$2.05M 0.04% 261
2018
Q1 		$5.56M Buy
225,654
+15,336
+7% +$403K 0.07% 173
2017
Q4 		$5.64M Buy
210,318
+65,820
+46% +$1.67M 0.08% 173
2017
Q3 		$3.48M Buy
144,498
+12,084
+9% +$273K 0.06% 229
2017
Q2 		$2.83M Buy
132,414
+108,164
+446% +$2.18M 0.05% 252
2017
Q1 		$416K Buy
+24,250
New +$422K 0.01% 499
2016
Q1 		– Sell
-131,972
Closed -$3.83M – 499
2015
Q4 		$3.83M Buy
131,972
+15,972
+14% +$442K 0.13% 152
2015
Q3 		$3.15M Sell
116,000
-10,800
-9% -$306K 0.13% 152
2015
Q2 		$3.47M Buy
126,800
+2,400
+2% +$67.5K 0.11% 143
2015
Q1 		$3.32M Buy
124,400
+520
+0.4% +$12K 0.11% 140
2014
Q4 		$2.62M Buy
123,880
+46,880
+61% +$1.05M 0.1% 140
2014
Q3 		$1.83M Sell
77,000
-14,800
-16% -$341K 0.07% 180
2014
Q2 		$2.12M Buy
91,800
+21,800
+31% +$481K 0.05% 159
2014
Q1 		$1.6M Buy
+70,000
New +$1.49M 0.04% 180
2013
Q4 		– Sell
-30,000
Closed -$508K – 435
2013
Q3 		$508K Sell
30,000
-7,000
-19% -$118K 0.02% 344
2013
Q2 		$573K Buy
+37,000
New +$616K 0.03% 328

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Mirae Asset Global Investments's NVO Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Novo Nordisk (NVO) stake by 2,414% in Q2 2026, buying an estimated $12.3M and bringing the position to 297,881 shares worth $14.3M. The position accounts for 0.02% of the portfolio, ranked #378.

Mirae Asset Global Investments first reported a position in NVO in Q2 2013 and has held it in 48 quarters since. The position peaked at $85.4M in Q1 2025. 428 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Mirae Asset Global Investments held 297,881 shares of Novo Nordisk worth $14.3M as of Q2 2026.
  • Mirae Asset Global Investments bought 286,034 Novo Nordisk shares in Q2 2026, an estimated $12.3M.
  • Novo Nordisk made up 0.02% of Mirae Asset Global Investments's portfolio in Q2 2026, its #378 holding.
  • Mirae Asset Global Investments first reported a position in Novo Nordisk in Q2 2013 and has held it in 48 quarters since.
  • Mirae Asset Global Investments's Novo Nordisk position peaked at $85.4M in Q1 2025.
  • 428 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.